Skip to content
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year. BIO’s […]
Congressional action BIO wants to see in 2024 Read More »
The World Health Organization (WHO) has issued a warning for urgent measures amid an “alarming rise” in measles outbreaks in Europe last year. The
‘Alarming rise’ of measles outbreaks in Europe, WHO warns Read More »
Vaccines have changed the course of human history as we know it. Since the first vaccine was discovered in the late 1700s, vaccine technology
What does the vaccine pipeline look like – and how can we strengthen it? Read More »
The World Economic Forum (WEF) wrapped up its annual meeting in Davos last week, with global government and business leaders discussing the most pressing
Davos 2024: key takeaways on food, climate, and health Read More »
Four years after the start of the pandemic, it is well known that COVID-19 is linked with thrombosis. A new report from the Centers
CDC report: up-to-date COVID-19 vaccinations can protect against severe outcomes Read More »
Biotechnology can play a key role in improving human health and a better environment, help us curb food insecurity, and strengthening energy security while
We’re on the brink of a biotech ‘revolution,’ says NSCEB report Read More »
Recently, it’s seemed like everyone has been sick this winter—an observation that is not too far off. This year’s COVID surge is the second-highest
RSV recap: what to know about immunizations and safety in 2024 Read More »
J.P. Morgan’s massive Healthcare Conference wrapped last week. BIO was busy as ever in San Francisco, connecting companies with potential partners, discussing innovation, and
2024 JPM Healthcare Conference: top 5 BIO takeaways Read More »
After two decades of research and development, Sutro Biopharma is still a few years away from seeking market approval for its first drug, a
Loss of tax incentive for R&D threatens biotech innovation Read More »
Brad Bailey is Senior Vice President and U.S. General Manager for Genmab, a global biotechnology company at the forefront of discovering, developing, and delivering
Paving the way for patient-centricity in 2024 Read More »
